Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL1900091	SB12	eculizumab	Injection	Biological Products	Import Drug Application	2019-09-23	Samsung Bioepis Co., Ltd.	Samsung Bioepis Co Ltd	In Review	2019-09-21	view
JYSB1900139	依库珠单抗注射液	eculizumab	Injection	Biological Products	Supplementary Application	2019-07-05	杭州泰格医药科技股份有限公司	Hangzhou Tigermed Consulting Co Ltd	In Review	2019-07-04	view
JXSL1700032	依库珠单抗注射液	eculizumab	Injection	Biological Products	Import Drug Application	2017-06-22	杭州泰格医药科技股份有限公司	Hangzhou Tigermed Consulting Co Ltd	Certificate Issued	2018-09-10	view
JXSL1200054	依库珠单抗注射液	eculizumab	Injection	Biological Products	Import Drug Application	2012-07-10	杭州泰格医药科技股份有限公司	Hangzhou Tigermed Consulting Co Ltd	Certificate Issued	2016-04-21	view
JYSZ2200055	依库珠单抗注射液	eculizumab	Injection	Biological Products	License Renew	2022-10-19					view
JYSB2300165	依库珠单抗注射液	eculizumab	Injection	Biological Products	Supplementary Application	2023-09-19					view
JYSB2200186	依库珠单抗注射液	eculizumab	Injection	Biological Products	Supplementary Application	2022-09-27					view
JYSB2300025	依库珠单抗注射液	eculizumab	Injection	Biological Products	Supplementary Application	2023-02-11					view
JXSS2200041	依库珠单抗注射液	eculizumab	Injection	Biological Products(3.1)	Import Drug Application	2022-12-24					view
JXSS2200023	依库珠单抗注射液	eculizumab	Injection	Biological Products(3.1)	Import Drug Application	2022-07-18					view
JYSB2101213	依库珠单抗注射液	eculizumab	Injection	Biological Products	Supplementary Application	2022-01-12					view
JYSB2400075	依库珠单抗注射液	eculizumab	Injection	Biological Products	Supplementary Application	2024-04-04					view